
Nephros NEPH
$ 3.34
0.3%
Quarterly report 2026-Q1
added 05-07-2026
Nephros Operating Cash Flow 2011-2026 | NEPH
Annual Operating Cash Flow Nephros
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.64 M | -492 K | 827 K | -3.23 M | -1.42 M | -6.9 M | -2.28 M | -3.66 M | -77 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.64 M | -6.9 M | -1.73 M |
Quarterly Operating Cash Flow Nephros
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.67 M | - | - | 322 K | - | - | - | -672 K | - | - | - | 276 K | - | -3.04 M | -2.87 M | -1.8 M | - | -1.08 M | -172 K | -55 K | - | -5.38 M | -3.56 M | -1.84 M | - | -2.64 M | -2.03 M | -697 K | - | -3.13 M | -2.01 M | -669 K | - | -1.87 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 322 K | -5.38 M | -1.7 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
796 M | $ 67.88 | 0.55 % | $ 13.5 B | ||
|
Glaukos Corporation
GKOS
|
-14.8 M | $ 126.81 | 2.05 % | $ 7.25 B | ||
|
Intuitive Surgical
ISRG
|
3.03 B | $ 411.06 | -0.45 % | $ 147 B | ||
|
Alcon
ALC
|
1.34 B | $ 66.85 | 0.51 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
180 M | $ 142.2 | -0.46 % | $ 3.5 B | ||
|
iRhythm Technologies
IRTC
|
80.9 M | $ 113.65 | 0.87 % | $ 3.64 B | ||
|
LeMaitre Vascular
LMAT
|
81.3 M | $ 91.96 | -0.41 % | $ 2.08 B | ||
|
Repro Med Systems
KRMD
|
462 K | $ 4.0 | - | $ 185 M | ||
|
Microbot Medical
MBOT
|
-13 M | $ 1.78 | -2.2 % | $ 81.5 M | ||
|
Masimo Corporation
MASI
|
196 M | $ 179.95 | - | $ 9.59 B | ||
|
Ekso Bionics Holdings
EKSO
|
-11.8 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
-2.92 M | $ 0.35 | -2.51 % | $ 28.7 M | ||
|
Merit Medical Systems
MMSI
|
297 M | $ 66.53 | -0.54 % | $ 3.94 B | ||
|
electroCore
ECOR
|
-8.19 M | $ 10.25 | 0.69 % | $ 87 K | ||
|
Envista Holdings Corporation
NVST
|
276 M | $ 24.6 | 0.41 % | $ 4.13 B | ||
|
Haemonetics Corporation
HAE
|
293 M | $ 78.2 | -2.05 % | $ 3.69 B | ||
|
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | ||
|
Utah Medical Products
UTMD
|
14.7 M | $ 67.84 | -2.3 % | $ 220 M | ||
|
STERIS plc
STE
|
1.34 B | $ 207.56 | 0.16 % | $ 20.4 B | ||
|
STAAR Surgical Company
STAA
|
-34.2 M | $ 28.37 | -1.83 % | $ 1.41 B | ||
|
InfuSystem Holdings
INFU
|
24.4 M | $ 9.14 | 0.99 % | $ 189 M | ||
|
West Pharmaceutical Services
WST
|
755 M | $ 328.82 | -0.46 % | $ 23.8 B | ||
|
Pulse Biosciences
PLSE
|
-54.1 M | $ 24.37 | -9.37 % | $ 1.64 B | ||
|
DENTSPLY SIRONA
XRAY
|
235 M | $ 10.09 | -0.49 % | $ 2.01 B | ||
|
Retractable Technologies
RVP
|
-7.06 M | $ 0.7 | -0.03 % | $ 21 M | ||
|
Pro-Dex
PDEX
|
-1.68 M | $ 62.2 | -1.14 % | $ 205 M | ||
|
Predictive Oncology
POAI
|
-13.2 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
20.1 M | $ 26.1 | -1.88 % | $ 1.25 B | ||
|
Stereotaxis
STXS
|
-13.7 M | $ 1.84 | 1.1 % | $ 167 M | ||
|
Baxter International
BAX
|
845 M | $ 20.86 | 1.81 % | $ 10.7 B | ||
|
ResMed
RMD
|
351 M | $ 194.78 | 1.24 % | $ 28.5 B | ||
|
AtriCure
ATRC
|
57.3 M | $ 28.79 | 1.34 % | $ 1.37 B | ||
|
Harvard Bioscience
HBIO
|
6.73 M | $ 6.08 | -8.43 % | $ 270 M | ||
|
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
-10.1 M | $ 12.1 | 0.17 % | $ 494 M | ||
|
Becton, Dickinson and Company
BDX
|
3.33 B | $ 146.24 | -0.75 % | $ 42.1 B | ||
|
OraSure Technologies
OSUR
|
-49 M | $ 4.18 | -0.24 % | $ 307 M | ||
|
Repligen Corporation
RGEN
|
117 M | $ 130.59 | -2.06 % | $ 7.34 M |